CAS 1416153-62-2

Ethyl5-[[[[3'-(Methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl][(2,4,6-trimethylphenyl)sulfonyl]amino]methyl]-2-furancarboxylate

CAS: 1416153-62-2

Fórmula: C₃₁H₃₃NO₇S₂

Pureza: 98%

Peso molecular: 595.7262

Ref: IN-DA01ENKV

SR9238

CAS: 1416153-62-2

SR9238

Pureza: ≥98%

Peso molecular: 595.73g/mol

Ref: 54-BUP02140

SR9238

CAS: 1416153-62-2

SR9238 is a synthetic agonist of liver X receptor inverse (IC50s: 214 nM and 43 nM for LXRα and LXRβ, respectively).

Fórmula: C₃₁H₃₃NO₇S₂

Pureza: 98.99% - 99.95%

Cor e Forma: Solid

Peso molecular: 595.73

Ref: TM-T16930

SR 9238

Produto Controlado

CAS: 1416153-62-2

Fórmula: C₃₁H₃₃NO₇S₂

Cor e Forma: Neat

Peso molecular: 595.726

Ref: TR-S684520

SR9238

CAS: 1416153-62-2

SR9238 is a drug that is being developed for the treatment of hepatic steatosis, which is a condition characterized by excessive fat accumulation in the liver. It has been shown to reduce plasma glucose levels, fatty acid synthesis, and cholesterol synthesis in animal models. SR9238 also shows promising effects on insulin resistance, which is a condition that leads to diabetes. This drug has been shown to inhibit site-specific chemical reactions in cells, such as the biosynthesis of phospholipids and triglycerides. SR9238 has also been shown to increase cancer cell viability in cell culture studies and reduce atherosclerotic lesion size in mouse models.

Fórmula: C₃₁H₃₃NO₇S₂

Pureza: Min. 95%

Peso molecular: 595.73 g/mol

Ref: 3D-RGC15362